Mehmet KABAK, Barış ÇİL, İCLAL HOCANLI, CENGİZHAN SEZGİ, MAHŞUK TAYLAN, Ufuk DÜZENLİ

Tuberculosis Cases in Mardin Between 2012 And 2018

Tuberculosis (TB) is a respiratory-borne disease. It can hold most of the lungs and other tissues and organs. In this study, we aimed to offer the clinical and demographic data of TB patients who were followed -up in our province between 2012 and 2018. In our province, tuberculosis dispensary records were examined retrospectively between 2012 and 2018. Of 249 patients, 125 (50.2%) were females and 124 (49.8%) were males. The mean age of the patients was 37.5 years. There were 132 (53%) patients with pulmonary tuberculosis, 112 (45%) with extrapulmonary tuberculosis and 5 (2%) patients with both pulmonary and extrapulmonary tuberculosis. 239 cases (96%) were new cases and 10 (4%) patients had recurrence. While 109 (43.8%) of the patients had smear positivity, 13 patients (5.4%) were diagnosed with pleural biopsy and 87 (34.6%) patients were diagnosed histopathologically with lymph and other organ biopsies. In 13 (5.4%) patients, only ADA elevation and 27 (10.8%) patients were diagnosed clinically and radiologic. 111 (44.6%) patients had no contact and 38 (15.3%) patients had a history of in- house or out - of - home contact. In addition, 100 (40.2%) patients had no known contact. 101 of our patients have studied culture, 20 of them have culture negativity, 81 of them have culture positivity. 5 patients had rifampicin resistance, 4 had streptomycin resistan ce, 5 had ethambutol resistance and 11 had isoniazid resistance. While 6 (2.4%) patients were dead, 78 (31.3%) patients were cured. Treatment success was achieved in 153 (61.5%) patients and treatment was abandoned in 8 (3.2%) patients. Tuberculosis is a disease that affects especially young people. Early diagnosis and treatment of TB patients are especially important for infectious diseases.

PDF

___

1. Ramma L, Cox H, Wilkinson L, et al. Patients’ costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa Int J Tuberc Lung Dis 2015; 19: 1513- 1519.

2. Wingfield T, Tovar M.A, Huff D, et al. The economic effects of supporting tuberculosisaffected households in Peru Eur Respir J 2016; 48: 1396-1410.

3. Guidelines for the diagnosis and treatment of tuberculosis 2011

4. Verguet S, Riumallo-Herl C, Gomez G.B, et al. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study Lancet Glob Health 2017; 5: 1123-1132.

5. Koçakog lu Ş, Şimşek Z, Ceylan E. Epidemiologic Characteristics of the Tuberculosis Cases Followed up at S anlıurfa Central Tuberculosis Control Dispensary between 2001 and 2006 Years. Tur Toraks Der 2009; 10: 9-14.

6. Özbay B, Sezgi C, Altınöz O, Sertog ullarından B, Tokgöz N. I limizde 1999-2003 yılları arasında saptanan tüberküloz olgularının deg erlendirilmesi. Tub Toraks 2008; 56: 396-404.

7. Kaya H, Çiftçi F, Sezer O, Bozkanat E, Tas D, Kartalog lu Z. Hastanemizde 2006 Yılında Tüberküloz Tanısı Alan Hastaların Tedavi Sonuçları. Solunum 2009; 11: 109-114.

8. Ateş G, Ataman A, Ekinci Ş. Diyarbakır 1 No’lu Verem Savas ı Dispanseri’nde 2004 Yılında Tedaviye Alınan Tüberküloz Olgularının Retrospektif Olarak Deg erlendirilmesi Fırat Tıp Dergisi 2006; 12: 59-61.

9. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 1998. August 1999.

10. Agarwal SP. TB across the globe (2). Tuberculosis in India. The past and the prospects for the future. Scot Med J 2000; 45: 11-13.

11. Özkara S , Kılıçarslan Z, Öztürk F et al. Bölge verileriyle Türkiye’de tüberküloz. Toraks Dergisi 2002; 3: 178-187.

12. Kocabas A. Tüberküloz tedavisinin temelleri. Tüberküloz Klinig i ve Kontrolü. Adana: Çukurova Üniversitesi Basımevi 1991; 273-293.

13. Moore RD, Chaulk CP, Griffiths R, et al. Costeffectiveness of directly observed versus selfadministered therapy for tuberculosis. Am J Respir Crit Care Med 1996; 154: 1013-1019.

14. Kolsuz M, Ersoy M, Küçükkebapçı C et al. Eskis ehir Deliklitas Verem Savas Dispanseri’nde kayıtlı akcig er tüberkülozlu olgularının deg erlendirilmesi. Solunum Has- talıkları 2003; 14: 163-170.

15. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-161.

16. Alışkan HE, Bostanoğlu E, Turunç T et al. Retrospektif Olarak Tüberküloz Laboratuvarının Altı Yıllık Sonuçları ve Antimikobakteriyel İlaçlara Direnç Oranları. Turk Toraks Derg 2013; 14: 53- 58.